Marta Torres-Narbona

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

Jesús Guinea, Marta Torres-Narbona, Paloma Gijón et al. · Clinical Microbiology and Infection · 2009 · 392 citations

Epidemiology, Advanced Lung Disease, Pathology +5

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, <i>Candida</i> , <i>Aspergillus</i> , <i>Fusarium</i> , and <i>Scedosporium</i> Species

Jesús Guinea, Teresa Peláez, Sandra Recio et al. · Antimicrobial Agents and Chemotherapy · 2008 · 211 citations · Full text

Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain

Marta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón et al. · Journal of Clinical Microbiology · 2007 · 117 citations · Full text

Diagnostic Mycology, Laboratory Workload, Population-based Study +13

In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

Marta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón et al. · Antimicrobial Agents and Chemotherapy · 2006 · 66 citations · Full text

Medicinal Chemistry, Antifungal Agent, Active Drug +13

Rapid Antifungal Susceptibility Determination for Yeast Isolates by Use of Etest Performed Directly on Blood Samples from Patients with Fungemia

Jesús Guinea, Sandra Recio, Pilar Escribano et al. · Journal of Clinical Microbiology · 2010 · 56 citations · Full text

Blood Samples, Yeast Isolates, Diagnostic Mycology +19